...
首页> 外文期刊>International immunopharmacology >Blend of organic acids and medium chain fatty acids prevents the inflammatory response and intestinal barrier dysfunction in mice challenged with enterohemorrhagic Escherichia coli O157:H7
【24h】

Blend of organic acids and medium chain fatty acids prevents the inflammatory response and intestinal barrier dysfunction in mice challenged with enterohemorrhagic Escherichia coli O157:H7

机译:有机酸和中链脂肪酸的混合物可防止小鼠煽动炎症反应和肠道屏障功能障碍,肠道饲料大肠杆菌O157:H7

获取原文
获取原文并翻译 | 示例

摘要

Impaired epithelial barrier function disrupts immune homeostasis and increases inflammation in intestines, leading to many intestinal diseases. The blend of organic acids (OAs) and medium chain fatty acids (MCFAs) has been shown to have synergistic bactericidal effect. In this study, we demonstrated that two blends of OAs and MCFAs (OM1 and OM2) could prevent the inflammatory response and intestinal barrier dysfunction in enterohemorrhagic Escherichia coli (EHEC)-infected mice. Treatments of OM1 and OM2 significantly reduced the body weight loss and production of IL-6 and TNF-alpha induced by EHEC. Mice treated with OM1 and OM2 showed decrease in serum D-lactic concentration, DAO activity and bacterial transfer to liver and spleen. Furthermore, OM1 and OM2 increased the expression of tight junction proteins occludin and ZO-1, mucus protein MUC-2, and host defense peptides mBD1, mBD2 and mBD3. Finally, OM1 and OM2 increased the population of Lactobacillus spp. and Bifidobacterium spp., but decreased that of E. colt in the cecum. These findings indicate that OM1 and OM2 may be used to develop a prophylactic agent for intestinal inflammation and injury in enteric pathogen infection.
机译:损伤的上皮屏障功能扰乱了免疫稳态,并增加了肠道中的炎症,导致许多肠道疾病。有机酸(OAS)和中链脂肪酸(MCFAs)的共混物已被证明具有协同杀菌效应。在这项研究中,我们证明了OAS和MCFAS(OM1和OM2)的两个共混物可以防止肠溶性大肠杆菌(EHEC)的小鼠中的炎症反应和肠道屏障功能障碍。 OM1和OM2的治疗显着降低了EHEC诱导的IL-6和TNF-α的体重减轻和生产。用OM1和OM2处理的小鼠显示血清D-乳酸浓度,DAO活性和细菌转移到肝脏和脾脏的降低。此外,OM1和OM2增加了紧密结蛋白闭塞蛋白和ZO-1,粘液蛋白MUC-2和宿主防肽MBD1,MBD2和MBD3的表达。最后,OM1和OM2增加了Lactobacillus SPP的群体。和双歧杆菌。,但在盲肠中降低了大肠杆菌。这些发现表明OM1和OM2可用于开发用于肠炎症和肠道病原体感染的损伤的预防剂。

著录项

  • 来源
    《International immunopharmacology 》 |2018年第2018期| 共8页
  • 作者单位

    Huazhong Agr Univ Coll Anim Sci &

    Technol Dept Anim Nutr &

    Feed Sci Wuhan 430070 Hubei Peoples;

    Huazhong Agr Univ Coll Anim Sci &

    Technol Dept Anim Nutr &

    Feed Sci Wuhan 430070 Hubei Peoples;

    Huazhong Agr Univ Coll Anim Sci &

    Technol Dept Anim Nutr &

    Feed Sci Wuhan 430070 Hubei Peoples;

    Huazhong Agr Univ Coll Anim Sci &

    Technol Dept Anim Nutr &

    Feed Sci Wuhan 430070 Hubei Peoples;

    Huazhong Agr Univ Coll Anim Sci &

    Technol Dept Anim Nutr &

    Feed Sci Wuhan 430070 Hubei Peoples;

    Huazhong Agr Univ Coll Anim Sci &

    Technol Dept Anim Nutr &

    Feed Sci Wuhan 430070 Hubei Peoples;

    Cooperat Innovat Ctr Sustainable Pig Prod Wuhan 430070 Hubei Peoples R China;

    Huazhong Agr Univ Coll Anim Sci &

    Technol Dept Anim Nutr &

    Feed Sci Wuhan 430070 Hubei Peoples;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学 ;
  • 关键词

    Tight junction; Medium chain fatty acids; Organic acids; Intestinal permeability;

    机译:紧缩结;中链脂肪酸;有机酸;肠道渗透性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号